Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

University of Toronto

$146,666.00

An Evaluation of Adjuvant Treatments to Mechanical Ventilation for Acute Respiratory Failure

FY 2014-15

Summary
Respiratory failure (lung disease and breathing failure) is a common cause of admission to the intensive care unit (ICU) requiring mechanical ventilation (life support breathing machine). At times the disease is so severe that the breathing machine is insufficient to keep the individual alive; therefore, additional therapies and strategies are required as advanced forms of life support. These therapies include extracorporeal life support (artificial lung), high frequency oscillation (a specialized ventilator), continuous paralysis (medications causing muscle relaxation), corticosteroids (medications to reduce inflammation of the lungs) and pulmonary vasodilators (medications to enhance the delivery of oxygen). Existing research supporting the use of these therapies are conflicting and therefore their adoption across the world has been variable. This study has three specific aims: 1.to evaluate the actual use of these therapies across a diverse set of community and academic ICUs 2.to evaluate patient and hospital factors that drive the decision to use these therapies 3.to evaluate the impact of these therapies on survival in the real world outside of the context of strict and controlled research trials. This study will be performed using a large database of patients on life support with breathing failure from a group of structurally and geographically diverse hospitals. Information obtained from this study can help inform the creation of guidelines to direct physicians on when and how to use these therapies for patients and inform health care resource distribution. With the results of this study and more appropriate application of the use of these therapies, we could have a major impact on the survival of patients who develop respiratory failure.
Program
CIHR Fellowship
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
319456
Name
Munshi Laveena
Region
Ontario
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Health Research Training B - HP
Projecttitle
An Evaluation of Adjuvant Treatments to Mechanical Ventilation for Acute Respiratory Failure
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$146,666
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Acute Lung Injury; Acute Respiratory Distress Syndrome; Acute Respiratory Failure; Corticosteroids; Extracorporeal Life Support; Extracorporeal Membrane Oxygenation; High Frequency Oscillation; Inhaled Pulmonary Vasodilators; Mechanical Ventilation; Neuromuscular Blockading Agents
Abstract
Respiratory failure (lung disease and breathing failure) is a common cause of admission to the intensive care unit (ICU) requiring mechanical ventilation (life support breathing machine). At times the disease is so severe that the breathing machine is insufficient to keep the individual alive; therefore, additional therapies and strategies are required as advanced forms of life support. These therapies include extracorporeal life support (artificial lung), high frequency oscillation (a specialized ventilator), continuous paralysis (medications causing muscle relaxation), corticosteroids (medications to reduce inflammation of the lungs) and pulmonary vasodilators (medications to enhance the delivery of oxygen). Existing research supporting the use of these therapies are conflicting and therefore their adoption across the world has been variable. This study has three specific aims: 1.to evaluate the actual use of these therapies across a diverse set of community and academic ICUs 2.to evaluate patient and hospital factors that drive the decision to use these therapies 3.to evaluate the impact of these therapies on survival in the real world outside of the context of strict and controlled research trials. This study will be performed using a large database of patients on life support with breathing failure from a group of structurally and geographically diverse hospitals. Information obtained from this study can help inform the creation of guidelines to direct physicians on when and how to use these therapies for patients and inform health care resource distribution. With the results of this study and more appropriate application of the use of these therapies, we could have a major impact on the survival of patients who develop respiratory failure.
Competitiondate
201411
Approvedterm2
2 yrs 8 mths
Pinamesdelim
Munshi, Laveena
Approvedterm
2 ans 8 mois
Cihrcontribution2
~ $146,666~ $0~